FIELD: chemistry.
SUBSTANCE: what is presented is a recovered monoclonal antibody, which binds to PBP2a or PBP5 protein. The above antibody contains a heavy chain variable region having CDR1 region, which includes SEQ ID NO: 12, CDR2 region, which includes SEQ ID NO: 13, CDR3 region, which includes SEQ ID NO: 14, and a light chain variable region having CDR1 region, which includes SEQ ID NO: 6, CDR2 region, which includes SEQ ID NO: 7, CDR3 region, which includes SEQ ID NO: 8. What is also presented is a pharmaceutical composition containing the above antibody.
EFFECT: group of inventions has immunising action on an infection caused by bacteria possessing PBP2a or PBP5 protein.
4 cl, 20 dwg, 3 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMBINATIONS OF BACTERIOPHAGE LYSINE AND ANTIBIOTICS AGAINST GRAM-POSITIVE BACTERIA | 2013 |
|
RU2659208C2 |
| BIOFILM PREVENTION, DESTRUCTION AND TREATMENT BY BACTERIOPHAGE LYSIN | 2013 |
|
RU2646102C2 |
| PREVENTION, DESTRUCTION AND TREATMENT OF BIOFILM BY BACTERIOPHAGE LYSINE | 2013 |
|
RU2735103C2 |
| ANTIBODIES AGAINST TEICHOIC ACID CONJUGATE AND THEIR CONJUGATES | 2014 |
|
RU2687044C2 |
| COMPOSITIONS AND METHODS FOR TREATMENT AND PREVENTION OF INFECTIONS CAUSED BY STAPHYLOCOCCUS AUREUS | 2015 |
|
RU2636780C1 |
| METHODS OF TREATMENT AND PREVENTION OF STAFILOCOCCA INFECTIONS OF GOLDEN AND RELATED DISTURBANCES | 2012 |
|
RU2635462C2 |
| TREATMENT OF INFECTION CAUSED BY MICROORGANISMS | 2002 |
|
RU2303460C2 |
| ANTIBODIES OR THEIR FRAGMENTS, AIMED AGAINST STAPHYLOCOCCUS AUREUS EPITOPE | 2010 |
|
RU2560415C2 |
| ANTIBODIES FOR SPECIFIC BINDING OF STAPHYLOCOCCUS AUREUS ALPHA-TOXIN AND METHODS OF APPLICATION | 2012 |
|
RU2620065C2 |
| PHARMACEUTICAL COMPOSITION FOR TREATING EYE INFECTIONS CAUSED BY METICILLIN-RESISTANT STRAINS OF STAPHYLOCOCCUS AUREUS, WHICH INCLUDES AS ACTIVE INGREDIENT N-TERMINAL CHAP-DOMAIN OF ENDOLYSIN OF BACTERIOPHAGE K STAPHYLOCOCCUS AUREUS | 2019 |
|
RU2715694C1 |
